Study Name:
Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban: Prospective Management Trial (HOT-PE study)

Phase:
Phase 4 Clinical Trial

EudraCT number:
2013-001657-28

National Investigator Coordinator:
Prof. Doctor Cândida Fonseca

Sponsor:
University Medical Center of the Johannes Gutenberg, University Mainz, Germany

Participating countries:
Spain, Italy, Greece, Germany, Finland, the Netherlands and Portugal

Sites in Portugal:
Centro Hospitalar Lisboa Ocidental – Hospital S. Francisco Xavier, Hospital Garcia d’Orta, Centro Hospitalar Vila Nova de Gaia, Centro Hospitalar de São João, Centro Hospitalar Universitário de Coimbra, Centro Hospitalar do Porto, Hospital da Luz

Status:
Recruitment finished